RAB28P2

Across TCGA pan-cancer cohorts, RAB28P2 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RAB28P2 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RAB28P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RAB28P2 expression acts as an unfavorable survival marker.

HNSC, STAD, and SKCM are the cancer types where RAB28P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	III,IV	0.128	0.680	.005	36	view →
STAD	OS	Tertile	II,III,IV	0.496	0.724	.030	27	view →
SKCM	DFS	Tertile	II,III,IV	0.205	0.594	.009	27	view →
PCPG	DFS	Tertile	All	0.283	0.782	<.001	27	view →
KIRP	OS	Tertile	III,IV	0.268	0.808	.012	18	view →
COAD	OS	Tertile	II,III,IV	0.196	0.788	.010	18	view →
SARC	OS	Tertile	All	0.109	0.514	.016	12	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RAB28P2–HNSC (DFS)

Open the HNSC breakdown →